Your search for major depressive disorder returned 13 results

Lauren R. Natbony, MD, takes us on a deep dive into the association between nutrition and dietary patterns in migraine, including proposed mechanisms, and the remaining needs in patient education and research.

In part 2 of this 2-part series, gynecologist Nichole Tyson, MD, and Samuel Frank, her researcher assistant, emphasize the importance of neurologists and gynecologists to work together to optimize patient care in menstrual-related epilepsy.

The link between head injury and dementia risk is not straightforward, but a neurologist and neuropsychologist discuss potential mechanisms and prevention efforts that can help increase awareness and minimize cognitive problems.

An expert roundtable of headache specialists helps outline chronic migraine as its own entity, disparities and barriers to treatment, and a need for better research and education.

In an interview, sleep medicine experts Milena K Pavlova, MD, and Rachel Ziegler, MD, discuss the latest developments in sleep disorder therapies and the existing gaps in sleep medicine.

Neurology advisor spoke with Charuta Joshi, MBBS regarding the use of the cannabis-based Epidiolex in the treatment of pediatric seizures.

We interview experts Younghoon Kwon, MD, MS, FACC, and Richard J Castriotta, MD, FCCP, FAASM, about the connections between obstructive sleep apnea-sudden cardiac death.

Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.

Atrial fibrillation, which affects up to 46.3 million people globally and 2.7 to 6.1 million individuals in the US, may represent a modifiable risk factor for acute stroke.

Common comorbidities in OSA such as cardiovascular disease and metabolic abnormalities, may confer a higher risk for the development of mental and cognitive impairment in patients with OSA compared with the general population.

Rates of HIV-associated dementia have decreased from approximately 50% in the pre-cART era to 2% currently. However, roughly 50% of patients treated with cART have the milder forms of HIV-associated neurocognitive disorder (HAND).

Georgia has been added to the growing list of states, including Kentucky, Ohio, Mississippi, and Tennessee, that have passed so-called fetal heartbeat bills.

Clinicians should know that chemotherapy-induced cognitive impairment, chemobrain, chemofog, or whatever you want to call it is a real phenomenon.